Clearside Biomedical Inc (CLSD NASDAQ) stock market data APIs
$0.4076
0.16(39.3%)
as of November 28, 2025
Try our APIs with
free plan!
Clearside Biomedical Inc Financial Data Overview
Price chart is built with
Anychart
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. On November 23, 2025, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Prev. Close
0.4076
Open
0.5717
High
0.5745
Low
0.388
52 wk Range
0.3917-17.1
Market Cap
2 146 K
Shares Outstanding
5 234 K
Revenue
3 329 K
EPS
-1.14
Beta
1.787
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Clearside Biomedical Inc data using free add-ons & libraries
Get Clearside Biomedical Inc Fundamental Data
Clearside Biomedical Inc Fundamental data includes:
- Net Revenue: 3 329 K
- EBITDA: -22 630 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: -0.0671
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Clearside Biomedical Inc News
New
Key medical device brand for files Chapter 11 bankruptcy
Investors struggle with valuation on health care and medical companies, since having drugs and treatments in various stages of testing does not guarantee approval. And it's more complicated than that...
Clearside Biomedical Files For Chapter 11 Bankruptcy
(RTTNews) - Clearside Biomedical, Inc. (CLSD) announced that it has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code in the District of Delaware, with plans to pursue a structur...
Clearside Biomedical Voluntary Files Petition For Chapter 11 Bankruptcy
(RTTNews) - Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company, announced Mondday that it has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy...
Clearside Biomedical files for Chapter 11
[Bankruptcy Chapter 11 is shown on the conceptual business photo] Andrii Dodonov * Clearside Biomedical (CLSD [https://seekingalpha.com/symbol/CLSD]) filed [https://seekingalpha.com/pr/20318035-cle...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
